For example, carcinoembryonic antigen (CEA)-targeting entities have been generated that show improved tumor-targeting in formats bivalent for CEA-binding, and improved efficacy with one of the CEA-binders arranged in a head-to-tail configuration with the CD3-binder23. This evidence concerns the gene CEACAM5 and neoplasm.